Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Revive Therapeutics' bucillamine receives orphan drug designation for cystinuria

Oct. 30, 2015

Researchers devise mouse model of nocturnal polyuria

Oct. 26, 2015

AF-219 improves symptoms in patients with interstitial cystitis/bladder pain syndrome

Oct. 26, 2015

Cinryze receives FDA fast track designation

Oct. 14, 2015

Astellas Pharma describes prostanoid EP4 antagonists

Oct. 14, 2015

New financing round at Pharmalink to fund development of phase III program for Nefecon

Oct. 6, 2015

Fexeric approved in Europe for hyperphosphatemia in patients with chronic kidney disease

Sep. 25, 2015

NecroX-7 reduces renal ischemia-reperfusion injury in vivo

Sep. 17, 2015

Topline phase II data on GKT-137831 support development in fibrotic diseases

Sep. 9, 2015

Cytori stem cell therapy ECCS-50 enters phase III trial in male urinary incontinence

Sep. 8, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...